CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 9/29/2026

1. NTAP
2. SPY
3. NVDA
4. MDB
5. ORCL
6. MTN
7. META
8. AIR
9. FFAI
10. SPCX

Go back to CEL-SCI to Initiate Multikine Confirmatory Phase 3 Cancer Trial
CEL-SCI CORPORATION (NYSE: CVM) Delayed: 1.79 +0.09 (5.29%)
Previous Close $1.70    52 Week High $0.66 
Open $1.70    52 Week Low $0.20 
Day High $1.79    P/E N/A 
Day Low $1.70    EPS $-0.34 
Volume 74,544